Purchases and Sales Made in Q4 2023 in Blueprint Medicines Corp (BPMC)
This table provides information about the institutional ownership of Blueprint Medicines Corp (BPMC) during Q4 2023. The information is specifically focused on institutions that hold shares of Blueprint Medicines Corp.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2024
Q4 2023
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-40K- 81.63% |
$1.76M - $3.71M
|
9K
$814K
|
|
Feb 14, 2024
Q4 2023
|
Casdin Capital, LLC
New York, NY |
SELL
|
- |
-45K- 12.12% |
$1.98M - $4.18M
|
326K
$29.5M
|
|
Feb 13, 2024
Q4 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-45.3K- 27.19% |
$1.99M - $4.21M
|
121K
$11M
|
|
Feb 14, 2024
Q4 2023
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-53.2K- 34.27% |
$2.34M - $4.94M
|
102K
$9.23M
|
|
Jan 26, 2024
Q4 2023
|
Peregrine Capital Management LLC
|
SELL
|
- |
-54.9K- 37.43% |
$2.41M - $5.1M
|
91.8K
$8.3M
|
|
Feb 06, 2024
Q4 2023
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
SELL
|
- |
-55.3K- 14.49% |
$2.43M - $5.14M
|
327K
$29.5M
|
|
Feb 05, 2024
Q4 2023
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-58.7K- 59.46% |
$2.58M - $5.45M
|
40K
$3.62M
|
|
Feb 14, 2024
Q4 2023
|
Granahan Investment Management, LLC
Waltham, MA |
SELL
|
- |
-61.7K- 26.93% |
$2.71M - $5.73M
|
168K
$15.2M
|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-67.6K- 1.23% |
$2.97M - $6.28M
|
5.43M
$491M
|
|
Feb 05, 2024
Q4 2023
|
Emerald Mutual Fund Advisers Trust
|
SELL
|
- |
-84.1K- 18.1% |
$3.7M - $7.8M
|
380K
$34.4M
|
|
Feb 14, 2024
Q4 2023
|
Candriam S.C.A.
|
SELL
|
- |
-85K- 62.86% |
$3.74M - $7.89M
|
50.2K
$4.54M
|
|
Feb 07, 2024
Q4 2023
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-91.7K- 53.41% |
$4.03M - $8.51M
|
80K
$7.23M
|
|
Feb 14, 2024
Q4 2023
|
Aquilo Capital Management, LLC
San Francisco, CA |
SELL
|
- |
-124K- 32.78% |
$5.46M - $11.5M
|
255K
$23.1M
|
|
Feb 14, 2024
Q4 2023
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-126K- 28.76% |
$5.54M - $11.7M
|
312K
$28.3M
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-132K- 56.93% |
$5.82M - $12.3M
|
100K
$9.06M
|
|
Feb 14, 2024
Q4 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-137K- 18.17% |
$6M - $12.7M
|
615K
$55.6M
|
|
Feb 14, 2024
Q4 2023
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-139K- 55.57% |
$6.1M - $12.9M
|
111K
$10M
|
|
Feb 14, 2024
Q4 2023
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-139K- 9.3% |
$6.12M - $12.9M
|
1.36M
$123M
|
|
Feb 05, 2024
Q4 2023
|
Emerald Advisers, LLC
|
SELL
|
- |
-141K- 23.16% |
$6.18M - $13.1M
|
466K
$42.2M
|
|
Feb 14, 2024
Q4 2023
|
Sectoral Asset Management Inc
Montreal, A8 |
SELL
|
- |
-163K- 98.51% |
$7.18M - $15.2M
|
2.47K
$223K
|
|
Feb 14, 2024
Q4 2023
|
Novo Holdings
Hellerup, G7 |
SELL
|
- |
-166K- 31.6% |
$7.29M - $15.4M
|
359K
$32.5M
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-175K- 10.3% |
$7.67M - $16.2M
|
1.52M
$137M
|
|
Feb 14, 2024
Q4 2023
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-175K- 16.83% |
$7.69M - $16.2M
|
865K
$78.2M
|
|
Feb 14, 2024
Q4 2023
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-180K- 81.82% |
$7.91M - $16.7M
|
40K
$3.62M
|
|
Feb 14, 2024
Q4 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-201K- 7.67% |
$8.85M - $18.7M
|
2.42M
$219M
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-226K- 71.72% |
$9.95M - $21M
|
89.2K
$8.07M
|
|
Feb 13, 2024
Q4 2023
|
Alkeon Capital Management LLC
New York, NY |
SELL
|
- |
-300K- 31.78% |
$13.2M - $27.9M
|
644K
$58.2M
|
|
Feb 14, 2024
Q4 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-555K- 93.21% |
$24.4M - $51.6M
|
40.4K
$3.66M
|
|
Feb 14, 2024
Q4 2023
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-859K- 34.96% |
$37.8M - $79.8M
|
1.6M
$145M
|